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A 62-year-old female presented with right upper quadrant pain. Clinical examination and ultrasound scan were consistent with
gallstones and acute cholecystitis. She received 3 days of intravenous Co-amoxiclav and was discharged with 5-days of oral
antibiotics with arrangements to return for an elective cholecystectomy. This was performed 5 months later which revealed an
inﬂamed gallbladder and a localised abscess secondary to gallbladder perforation. Fluid from the gallbladder was taken which
cultured Raoultella planticola, a gram-negative, nonmotile environmental bacteria (Bagley et al. (1981)). This is the ﬁrst report
of biliary sepsis with a primary infection by R. planticola. This patient was treated with a 5-day course of oral Co-amoxiclav and
made a full recovery.
1.Introduction
R. planticola is an aquatic, botanic, and soil organism that
does not typically cause invasive infections in humans.
There have only been 6 reported cases of serious infection
described in humans. We hereby report a case of cholecystitis
complicated by R. planticola.
2.CaseReport
A 62-year-old female patient presented to the Accident and
Emergency Department with abdominal pain and nausea.
She described a 3-week history of worsening right upper
quadrant pain but denied any nausea, vomiting, or fevers.
Her past medical history included coeliac disease, a hiatus
hernia, and irritable bowel syndrome. Her regular medica-
tions were Mebeverine, Omeprazole, and Movicol with no
knowndrugallergies.Sheworkedasacleaner,didnotsmoke,
and drank minimal alcohol. Of note, she had not travelled
recently,neverhadinstrumentationofherabdomen,anddid
not have any recent antimicrobial treatments. Speciﬁcally,
she denied any intentional or accidental ingestion of soil or
aquatic material.
On admission, she was apyrexial with normal observa-
tions. Signiﬁcant examination ﬁndings were that of localised
tenderness in the right upper abdominal quadrant, con-
sistent with acute cholecystitis. Blood tests revealed raised
inﬂammatory markers with mildly deranged liver func-
tion tests. (White Cell Count 24.0 × 109/L, Erythrocyte
Sedimentation Rate 98, C-Reactive protein 248, Bilirubin
12, Alkaline Phosphatase 189U/L, Alanine aminotransferase
58U/L, Gamma-glutamyl Transferase 141U/L, Albumin
37g/L). An ultrasound was performed which reported—
“The gallbladder is distended, containing debris and calculi.
It is thick walled, tender with some pericholecystic ﬂuid
around it. There is no drainable abscess or collections.
The ultrasound appearances are consistent with an acute
cholecystitis. The common bile duct is not dilated, and there
are no dilated intrahepatic ducts. Normal appearances of the
liver, spleen, and both kidneys.”
Shereceived3daysofintravenousCo-amoxiclav, andher
symptoms resolved. She was discharged with a 5-day course
of oral Co-amoxiclav with arrangements to return for an
elective laparoscopic cholecystectomy.
Five months after her initial presentation, she reattended
electively for a laparoscopic cholecystectomy. Due to adhe-
sions throughout the epigastrium and right upper quadrant,
thiswasconvertedtoanopenprocedure.Thegallbladderwas
buried in omentum, and there was a chronic abscess cavity
due to a localised perforation of the gallbladder. Fluid from2 Case Reports in Medicine
Table 1: Reports on clinical infection by R. planticola in humans.
Reference Location Clinical
manifestation Comorbidities
Invasive
procedure/trauma
prior to infective
episode
Treatment Outcome
Freney et al., [8] France Septicaemia Bacterial
endocarditis
Mitral valve
replacement
Cefotaxime and
Tobramycin Full recovery
Freney et al., [9] France Septicaemia and
pneumonia
Coronary artery
disease
Postcoronary artery
bypass graft Ceftriaxone Full recovery
Alves et al., [10]B r a z i l
Acute pancreatitis
and retroperitoneal
abscess
Pneumonia and
alcohol excess Nil Imipenem and
Amikacin Full recovery
O’Connell et al., [11]I r e l a n dCellulitis of the
thumb Nil Crush injury from
hammer
Benzyl penicillin,
Flucloxacillin,
Clindamycin, and
Ciproﬂoxacin
Full recovery
Wolcott and Dowd.,
[12] USA
Surgical site
infection following
∗ORIF of the left
tibia
Nil ∗ORIF
Cephalexin,
Clindamycin, and
Ertapenem
Full recovery
Yokota et al., [13] Japan Cholangitis
Metastatic
apocrine
adenocarcinoma of
the neck
∗∗ERCP
Cefoperazone-
sulbactam,
Meropenam and
piperacillin
tazobactam
Clinical
improvement
Current report UK Cholecystitis Coeliac disease,
hiatus hernia. Nil Co-amoxiclav Full recovery
∗ORIF: Open reduction and internal ﬁxation.
∗∗ERCP: Endoscopic retrograde cholangiopancreatography.
thegallbladderwassentformicrobiologicalexaminationand
a partial cholecystectomy performed.
Postoperatively the patient was systemically well. Her
observations were normal with no pyrexia, and she had
minimalpain.Thesurgicalteamwascontactedtwodaysafter
the operation and informed that viable Raoultella planticola
had been identiﬁed by VITEK 2 biochemical identiﬁcation
system with a very good probability of 99%. This was
sensitive to Co-amoxiclav, Ciproﬂoxacin, Cefuroxime, and
Tazocin. She was started on oral Co-amoxiclav following
discussion with the microbiology team. She continued to
make a good recovery and was discharged after a full 7-day
course of Co-amoxiclav.
She was reviewed 3 months after discharge with no new
complaints.
3. Discussion
R. planticola is a gram-negative, nonmotile bacilli primarily
considered to be environmental bacteria. Raoultella was
proposed as a genus in 2001, following the analysis of the
genus Klebsiella [1]. A comparative analysis of the sequences
of the 16S rRNA and rpoB genes were analysed, showing
the taxonomic heterogeneity of Klebsiella which form three
clusters; cluster II organisms were characterised by growth at
10 degrees Celsius and utilisation of L-sorbose as a carbon
source, and the name Raoultella was created as a genus name
for this species of cluster II organisms [2, 3]. Until this
time, this organism was known that was being part of the
Klebsiellagenuswhichwasﬁrstdescribedin1981asKlebsiella
planticola and later in 1983 as Klebsiella trevisanii.
Many Klebsiella species are indistinguishable by the
conventional methods employed routinely in the clinical
microbiology laboratory. There are several recommended
additional tests [1, 3–5] to conﬁrm the subspecies of
Klebsiella, butthereiscurrentlynostandardizedtestavailable
[6]. In this patient, R. Planticola was identiﬁed using the
automated identiﬁcation system VITEK 2 with GN Identiﬁ-
cation Card (bioMerieux) with a probability of 99%. Whilst
this is a high probability, conﬁrmation of identiﬁcation
could be strengthened by additional tests or conﬁrmed by a
national Klebsiella reference laboratory. This was not carried
out ﬁrstly because the microbiologists were conﬁdent with
the99%probability,andsecondlyasthepatientwasclinically
stable with a good response to Co-amoxiclav.
R. planticola has been reported as clinical isolates in
humans in sputum, stools, wounds, and urine [7, 8]b u ti s
a rare cause of invasive human infections. To date, there have
only been 6 reported cases of serious infection caused by this
organism in humans.
The ﬁrst case report was described by Freney et al.
[8] in Lyon, France where a 69-year-old patient with R.
planticola septicaemia was admitted to an intensive care unit
9 days following a mitral valve replacement [9]. In 1986,
Freney et al. [9] described a 57-year-old patient from the
same intensive care unit with severe pneumonia followingCase Reports in Medicine 3
a coronary artery bypass graft [8]. In 2007, Alves et al. [10]
in Brazil reported acute pancreatitis and a retroperitoneal
abscess in a 45-year-old-man [10]. In 2010, O’Connell et
al. [11] described a 30-year-old male in Ireland with soft
tissue infection following a crush injury to his thumb in a
soiled environment [11]. Also in 2010, Wolcott and Dowd
[12] reported a 66-year-old male who developed surgical
site infection of the lower limb following open reduction
and internal ﬁxation of a tibial fracture [12]. Most recently,
Yokota et al. [13] described a 65-year-old gentleman in
Japan developing septic shock and cholangitis caused by R.
Planticola [13].
A common theme is that 4 out of the 7 cases had
signiﬁcant comorbidities—Freney et al. [8]; Freney et al. [9];
Alves et al. [10]; Yokota et al. [13]. Another common theme
is that 5 of the 7 had some form of trauma or invasive
procedure prior to onset of systemic symptoms—Freney et
al. [8]; Freney et al. [9]; O’Connell et al. [11]; Wolcott and
Dowd [12]; Yokota et al. [13]. The patient in this report
did undergo a cholecystectomy; however, this was 5 months
after her episode of cholecystitis; hence, her procedure is
unlikely to have played a causative role in her infection. This
is summarised in Table 1.
4. Conclusion
In conclusion, R. planticola is an environmental bacterium
that can cause serious infections in humans. From previous
reports, we have identiﬁed the potential risk factors to
include invasive medical procedures, trauma with potential
soil contamination, and signiﬁcant comorbidities. Interest-
ingly, the patient in this report does not have any of these
risk factors. The clinical implications of this are uncertain;
nonetheless, the correct identiﬁcation of bacterial species
is essential to guide antimicrobial treatment and improve
clinical care.
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